Endra life sciences inc. (NDRA)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16
Revenue

-

-

0

0

-

0

0

0

6

-

287

57

-

-

-

-

-

Cost of goods sold

-

-

0

0

-

-

0

0

0

-

118

51

-

-

-

-

-

Revenue

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

-

Cost of Goods Sold

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

-

Gross Profit

-

-

0

0

-

0

0

0

6

3

168

6

0

-

0

0

-

Operating Expenses
Research and development

1,518

2,028

1,468

1,304

1,773

1,050

1,162

839

1,668

1,360

300

174

95

158

137

103

95

Sales and marketing

114

167

100

88

56

41

72

41

107

67

47

6

1

7

16

5

4

General and administrative

1,467

935

1,071

932

916

909

832

941

1,067

874

731

881

263

431

451

384

273

Impairment of inventory

-

-

0

-

-

-

287

-

-

-

-

-

-

-

-

-

-

Impairment of inventory

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

Total operating expenses

3,100

3,130

2,640

2,325

2,747

2,002

2,355

1,823

2,843

2,301

1,079

1,063

360

598

605

494

373

Operating loss

-3,100

-3,130

-2,640

-2,325

-2,747

-2,002

-2,355

-1,823

-2,837

-2,297

-910

-1,056

-360

-318

-605

-494

-373

Other Expenses
Amortization of debt discount

228

-

728

-

0

-

377

-

-

-

-

-

-

-

-

-

-

Loss on warrant exercise

-

-

-

-

-

-

-

-

-

-

-

-

-

11

0

0

-5

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

372

234

-

Total other expenses

-

-

-

-

-

-

-

-

-

-

-

374

380

375

372

234

0

Other income (expense)

6

-51

-44

-9

-1

-11

-25

-23

12

-

2

-

-

-

-

-

-6

Other income (expense)

6

-51

-44

-9

-1

-11

-25

-23

12

-

-

-

-

-

-

-

-

Total other expenses

-221

-1,678

-773

-9

-1

-362

-403

-23

12

-

2

-374

-380

-

-

-

-

Loss from operations before income taxes

-3,322

-4,809

-3,413

-2,334

-2,748

-2,365

-2,758

-1,846

-2,825

-2,294

-908

-1,431

-741

-688

-977

-729

-379

Provision for income taxes

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Net loss

-3,322

-

-3,413

-2,334

-2,748

-

-2,758

-1,846

-2,825

-2,294

-908

-1,431

-741

-688

-977

-729

-379

Net loss per share - basic and diluted

-0.29

-1.20

-0.46

-0.31

-0.37

-0.28

-0.70

-0.47

-0.72

-0.10

-0.23

-0.59

-1.03

-0.96

-1.35

-1.01

-0.52

Weighted average common shares - basic and diluted

11,508

7,725

7,428

7,422

7,422

6,245

3,927

3,923

3,923

3,960

3,907

2,437

723

723

723

723

723